Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

UFS sets deadline for applications
2006-11-07

The University of the Free State (UFS) calls on all prospective students wishing to study at the UFS in 2007 to submit their applications for admission by no later than 30 November 2006. 
 
“This applies to first-time entering first-year students and senior students who have interrupted their studies for at least one year,” said Mr Vernon Collett, Registrar: Academic Student Services at the UFS.
 
According to Mr Collett students whose applications for admission are received after 30 November 2006 and until 15 January 2007 will be accepted subject to the availability of place on the programme they applied for. 
 
“No applications of transfer students from other tertiary institutions who wish to continue their studies at the UFS will be accepted after 31 October 2006. After 5 January 2007 no applications will be accepted from prospective students with conditional exemptions,” said Mr Collett.
 
Prospective students who want to apply must pay a non-refundable fee of R120 into a designated account, which will be provided when the application form is sent to them. 
 
The signed application form must be accompanied by a certified copy of the prospective student’s identity document or passport and a proof of payment of the application fee. The application form of a minor must be signed by his/her parent or guardian and the field of study should be clearly indicated.
 
“More than 25 000 students are registered at the UFS Main Campus for the 2006 academic year. We expect a considerable number of applications and foresee that our numbers for next year will be similar to what it is now,” said Mr Collett.
 
First-time entering first-year students on the Main Campus will be welcomed by the Rector and Vice-Chancellor of the UFS, Prof Frederick Fourie, on 13 January 2007 at 11:00 in the Callie Human Centre.
 
The registration of first-time entering first-year students will commence on 16 January 2007 and that of senior students on 22 January 2007 at the Callie Human Centre according to a programme. 
 
Students who applied for admission after 30 November 2006 and are accepted can register from 5 February 2007. 
 
Lectures will commence on 5 February 2007 and the registration process will end on 9 February 2007.
 
Prospective students who want to apply for admission or who have any enquiries can call (051) 401-3000 or visit the UFS web site at www.uovs.ac.za.
 
Media release
Issued by: Lacea Loader
Media Representative
Tel:   (051) 401-2584
Cell: 083 645 2454
31 October 2006
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept